A Phase II, Open-Label, Randomized Study to Assess the Efficacy and Safety of AZD6244 (ARRY-142886) Versus Pemetrexed in Patients with Non-small Cell Lung Cancer Who Have Failed One or Two Prior Chemotherapeutic Regimens (Q42673662)
Jump to navigation
Jump to search
scientific article published on October 1, 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Phase II, Open-Label, Randomized Study to Assess the Efficacy and Safety of AZD6244 (ARRY-142886) Versus Pemetrexed in Patients with Non-small Cell Lung Cancer Who Have Failed One or Two Prior Chemotherapeutic Regimens |
scientific article published on October 1, 2010 |
Statements
1 reference
A phase II, open-label, randomized study to assess the efficacy and safety of AZD6244 (ARRY-142886) versus pemetrexed in patients with non-small cell lung cancer who have failed one or two prior chemotherapeutic regimens (English)
1 reference
A Phase II, Open-Label, Randomized Study to Assess the Efficacy and Safety of AZD6244 (ARRY-142886) Versus Pemetrexed in Patients with Non-small Cell Lung Cancer Who Have Failed One or Two Prior Chemotherapeutic Regimens (English)
John D Hainsworth
1 reference
Vladimir Kanarev
1 reference
Danail Damyanov
1 reference
Phillip Stella
1 reference
Hristo Ganchev
1 reference
Gillian Pover
1 reference
Clive Morris
1 reference
Valentina Tzekova
1 reference
Cristina L. Cebotaru
1 October 2010
1 reference
1 reference
5
1 reference
10
1 reference
1630-1636
1 reference
1 reference
Identifiers
1 reference
1 reference